| Literature DB >> 27895522 |
Karen L Caldwell1, Shawn M Bergman2, Scott R Collier3, N Travis Triplett3, Rebecca Quin4, John Bergquist5, Carl F Pieper6.
Abstract
OBJECTIVE: To determine feasibility and estimate the effect of a 10-week tai chi chuan (TCC) intervention on anxiety and sleep quality in young adults. PARTICIPANTS: Seventy-five adults (18-40 years) from a predominately undergraduate midsized university.Entities:
Keywords: anxiety; feasibility study; randomized controlled trial; sleep quality; tai chi chuan
Year: 2016 PMID: 27895522 PMCID: PMC5118018 DOI: 10.2147/NSS.S117392
Source DB: PubMed Journal: Nat Sci Sleep ISSN: 1179-1608
Figure 1CONSORT flow diagram for tai chi feasibility study.
Baseline participant characteristics by group
| Variable | Overall mean (SD) | Control group | Tai chi group | Enhanced tai chi | |
|---|---|---|---|---|---|
| Age | 21.1 (3.5) | 22.4 (5.5, 18, 40) | 21.2 (3.0, 18, 32) | 20.2 (1.2, 18, 24) | 0.1 |
| Gender | 0.8 | ||||
| Female | 51 | 14 | 18 | 19 | |
| Male | 24 | 5 | 10 | 9 | |
| Race | 0.9 | ||||
| White | 66 | 17 | 24 | 25 | |
| Non-white | 9 | 2 | 4 | 3 | |
| Ethnicity | 0.9 | ||||
| Hispanic or Latino | 7 | 2 | 3 | 2 | |
| Non-Hispanic | 67 | 17 | 25 | 25 | |
| No response | 1 | 0 | 0 | 1 | |
| STAI-S | 37.6 (8.9) | 35.3 (9.3) | 38.9 (8.0) | 37.9 (9.5) | 0.4 |
| PSQI total score | 6.6 (2.7) | 5.7 (3.0) | 7.3 (2.7) | 6.4 (2.4) | 0.1 |
| PSQI component 1, subjective sleep quality | 1.2 (0.5) | 1.2 (0.5) | 1.2 (0.4) | 1.0 (0.5) | 0.3 |
| PSQI component 2, sleep latency | 1.6 (1.0) | 1.3 (1.0) | 1.8 (0.8) | 1.5 (1.0) | 0.3 |
| PSQI component 3, sleep duration | 0.6 (0.7) | 0.5 (0.6) | 0.6 (0.8) | 0.6 (0.6) | 0.8 |
| Sleep duration raw data, hours | 7.2 (1.1) | 7.3 (1.2) | 7.2 (1.1) | 7.2 (1.0) | 0.7 |
| PSQI component 4, habitual sleep efficiency | 0.6 (0.9) | 0.5 (0.8) | 0.6 (1.0) | 0.8 (0.9) | 0.6 |
| Habitual sleep efficiency raw data, % | 85.9 (12.5) | 87.5 (13.2) | 86.7 (13.0) | 83.9 (11.3) | 0.2 |
| PSQI component 5, sleep disturbances | 1.3 (0.5) | 1.2 (0.5) | 1.5 (0.5) | 1.3 (0.5) | 0.1 |
| PSQI component 6, use of sleeping medication | 0.3 (0.6) | 0.2 (0.5) | 0.5 (0.9) | 0.1 (0.3) | 0.1 |
| PSQI component 7, daytime dysfunction | 1.0 (0.6) | 0.8 (0.6) | 1.1 (0.6) | 1.1 (0.6) | 0.1 |
Note:
p-values for differences across groups in baseline characteristics.
Abbreviations: STAI-S, state–trait anxiety inventory state; PSQI, Pittsburg sleep quality index; SD, standard deviation.
Adherent participants’ baseline and change scores at 4 weeks, 10 weeks (immediate post-intervention), and at 2 month follow-up by treatment group
| Retained control (N=17) | Tai chi | Hedges’ | ||||
|---|---|---|---|---|---|---|
| State anxiety | ||||||
| Baseline | 35.36 | 37.9 | ||||
| 4 weeks | −1.1(2.0) | 0.6 | −3.7 (1.4) | 0.01 | 0.3 | 0.3 |
| 10 weeks | −0.6 (2.1) | 0.8 | −4.3 (1.5) | <0.01 | 0.2 | 0.4 |
| 2 months follow-up | −1.1 (2.1) | 0.6 | −5.1 (1.5) | <0.01 | 0.1 | 0.4 |
| PSQI total scores | ||||||
| Baseline | 5.7 | 6.2 | ||||
| 4 weeks | −0.8 (0.4) | 0.1 | −1.3 (0.3) | <0.01 | 0.3 | 0.3 |
| 10 weeks | −1.4 (0.4) | <0.01 | −2.3 (0.3) | <0.01 | 0.1 | 0.5 |
| 2 months follow-up | −1.52 (0.44) | <0.01 | −3.25 (0.32) | <0.01 | <0.01 | 1.0 |
| PSQI component 1, subjective sleep quality | ||||||
| Baseline | 1.2 | 1.0 | ||||
| 4 weeks | −0.2 (0.1) | 0.2 | −0.2 (0.1) | 0.01 | 0.7 | 0.1 |
| 10 weeks | −0.1 (0.1) | 0.3 | −0.3 (0.1) | <0.01 | 0.3 | 0.3 |
| 2 months follow-up | −0.3 (0.1) | 0.03 | −0.5 (0.1) | <0.01 | 0.1 | 0.4 |
| PSQI component 2, sleep latency | ||||||
| Baseline | 1.3 | 1.5 | ||||
| 4 weeks | −0.7 (0.1) | <0.01 | −0.5 (0.1) | <0.01 | 0.5 | 0.2 |
| 10 weeks | −0.8 (0.1) | <0.01 | −1.0 (0.1) | <0.01 | 0.2 | 0.4 |
| 2 months follow-up | −0.8 (0.1) | <0.01 | −1.1 (0.1) | <0.01 | 0.1 | 0.5 |
| Sleep duration (hours) | ||||||
| Baseline | 7.3 | 7.3 | ||||
| 4 weeks | −0.1 (0.2) | 0.5 | 0.2 (0.2) | 0.3 | 0.3 | 0.4 |
| 10 weeks | −0.2 (0.2) | 0.3 | 0 (0.2) | 0.9 | 0.4 | 0.6 |
| 2 months follow-up | 0.7 (0.2) | <0.01 | 0.6 (0.2) | <0.01 | 0.6 | 0.01 |
| Habitual sleep efficiency (%) | ||||||
| Baseline | 87.5 | 86.3 | ||||
| 4 weeks | 2.5 (2.1) | 0.3 | 2.4 (1.5) | 0.1 | 1.0 | 0.01 |
| 10 weeks | 2.9 (2.2) | 0.2 | 1.9 (1.6) | 0.2 | 0.7 | 0.1 |
| 2 months follow-up | 1.7 (2.3) | 0.5 | 2.6 (1.6) | 0.1 | 0.7 | 0.1 |
| PSQI component 5, sleep disturbances | ||||||
| Baseline | 1.2 | 1.4 | ||||
| 4 weeks | −0.1 (0.1) | 0.2 | −0.1 (0.1) | 0.5 | 0.6 | 0.2 |
| 10 weeks | −0.1 (0.1) | 0.3 | −0.1 (0.1) | 0.1 | 0.8 | 0.1 |
| 2 months follow-up | 0.1 (0.1) | 0.5 | −0.3 (0.1) | <0.01 | 0 | 0.8 |
| PSQI component 6, use of sleeping medication | ||||||
| Baseline | 0.2 | 0.3 | ||||
| 4 weeks | 0.1 (0.1) | 0.4 | −0.1 (0.1) | 0.6 | 0.3 | 0.3 |
| 10 weeks | −0.1 (0.1) | 0.4 | 0 (0.1) | 0.7 | 0.3 | 0.3 |
| 2 months follow-up | 0 (0.1) | 1.0 | −0.1 (0.1) | 0.2 | 0.4 | 0.3 |
| PSQI component 7, daytime dysfunction | ||||||
| Baseline | 0.8 | 1.0 | ||||
| 4 weeks | −0.1 (0.1) | 0.4 | −0 (0.1) | 0.6 | 0.7 | 0.1 |
| 10 weeks | −0.5 (0.1) | <0.01 | −0.7 (1.1) | <0.01 | 0.2 | 0.4 |
| 2 month follow-up | −0.5 (0.1) | <0.01 | −0.8 (0.1) | <0.01 | 0.01 | 0.8 |
Notes: Baseline values were subtracted from values at 4 weeks, 10 weeks, and 2 month follow-up to calculate change scores such that negative results = reduction from baseline. Standard errors are shown in parentheses.
p-values are a result of comparing the change score at each time point within the group to zero.
Abbreviation: PSQI, Pittsburg sleep quality index.